FDA Okays Terlipressin (Terlivaz) for Hepatorenal Syndrome FDA Okays Terlipressin (Terlivaz) for Hepatorenal Syndrome

The synthetic vasopressin analogue is an injectable medication indicated for patients with hepatorenal syndrome who are experiencing rapid deterioration of kidney function (type 1 hepatorenal syndrome).FDA Approvals
Source: Medscape Gastroenterology Headlines - Category: Gastroenterology Tags: Gastroenterology News Alert Source Type: news